Abstract
Ten patients with exercise-induced asthma participated in a single-blind dose-response study comparing the protective effect of inhaled sodium cromoglycate in increasing concentrations from 2 to 40 mg/ml. Saline was used as a control. Effects were assessed from the mean maximal percentage fall in forced expiratory volume in one second (FEV1) after the patients had run on a treadmill for eight minutes. There was slight bronchodilation evident from the increase in baseline FEV1 after inhalation of sodium cromoglycate, the difference reaching statistical significance with the highest concentration (5.7%, p less than 0.05). After exercise the maximal percentage falls in FEV1 (means and SEM) after saline and after sodium cromoglycate at 2, 10, 20, and 40 mg/ml were 37.3 +/- 4.7, 17.3 +/- 4.1, 10 +/- 3.3, 7.6 +/- 2.4, and 12 +/- 2.9. Sodium cromoglycate inhibited the exercise-induced fall in FEV1 at all the concentrations used in the study (p less than 0.001) and its inhibitory effect increased from 2 to 20 mg/ml. The mean FEV1 returned to baseline values within 15 minutes at higher concentrations of sodium cromoglycate (20 and 40 mg/ml) and a small bronchodilator effect was noted at 30 minutes. The findings suggest that the protective effect of sodium cromoglycate in exercise asthma is dose related. At higher concentration the drug suppresses chemical mediator release from the lung mast cells and may also modify the bronchial reactivity to release mediators.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderton R. C., Cuff M. T., Frith P. A., Cockcroft D. W., Morse J. L., Jones N. L., Hargreave F. E. Bronchial responsiveness to inhaled histamine and exercise. J Allergy Clin Immunol. 1979 May;63(5):315–320. doi: 10.1016/0091-6749(79)90125-8. [DOI] [PubMed] [Google Scholar]
- Breslin F. J., McFadden E. R., Jr, Ingram R. H., Jr The effects of cromolyn sodium on the airway response to hyperpnea and cold air in asthma. Am Rev Respir Dis. 1980 Jul;122(1):11–16. doi: 10.1164/arrd.1980.122.1.11. [DOI] [PubMed] [Google Scholar]
- Chung J. T., Jones R. S. Bronchodilator effect of sodium cromoglycate and its clinical implications. Br Med J. 1979 Oct 27;2(6197):1033–1034. doi: 10.1136/bmj.2.6197.1033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cox J. S., Orr T. S., Pollard M. C., Gwilliam J. Mode of action of disodium cromoglycate, studies on immediate type hypersensitivity reactions using 'double sensitization' with two antigenically distinct rat reagins. Clin Exp Immunol. 1970 Nov;7(5):745–757. [PMC free article] [PubMed] [Google Scholar]
- Cox J. S., Woodard G. D., McCrone W. C. Solid-state chemistry of cromolyn sodium (disodium cromoglycate). J Pharm Sci. 1971 Oct;60(10):1458–1465. doi: 10.1002/jps.2600601003. [DOI] [PubMed] [Google Scholar]
- Davies S. E. Effect of disodium cromoglycate on exercise-induced asthma. Br Med J. 1968 Sep 7;3(5618):593–594. doi: 10.1136/bmj.3.5618.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Godfrey S., König P. Inhibition of exercise-induced asthma by different pharmacological pathways. Thorax. 1976 Apr;31(2):137–143. doi: 10.1136/thx.31.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McFadden E. R., Jr, Ingram R. H., Jr, Haynes R. L., Wellman J. J. Predominant site of flow limitation and mechanisms of postexertional asthma. J Appl Physiol Respir Environ Exerc Physiol. 1977 May;42(5):746–752. doi: 10.1152/jappl.1977.42.5.746. [DOI] [PubMed] [Google Scholar]
- Thomson N. C., Patel K. R., Kerr J. W. Sodium cromoglycate and ipratropium bromide in exercise-induced asthma. Thorax. 1978 Dec;33(6):694–699. doi: 10.1136/thx.33.6.694. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Woenne R., Kattan M., Levison H. Sodium cromoglycate-induced changes in the dose-response curve of inhaled methacholine and histamine in asthmatic children. Am Rev Respir Dis. 1979 Jun;119(6):927–932. doi: 10.1164/arrd.1979.119.6.927. [DOI] [PubMed] [Google Scholar]